Page last updated: 2024-08-21

adamantane and verapamil

adamantane has been researched along with verapamil in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's3 (50.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ferrara, JJ; Flint, LM; Force, SD; Franklin, EW; Hyman, AL; Lippton, HL; Taheri, PA1
Anwar, M; Banister, RE; Feng, CJ; Kadowitz, PJ; Kaye, AD; Nossaman, BD1
Huang, DY; Osswald, H; Vallon, V1
Balboni, G; Bryant, SD; Cooper, PS; Guerrini, R; Hardison, J; Lazarus, LH; Lovekamp, T; Salvadori, S1
Ackerley, C; Clarke, DM; De Rosa, MF; Ito, S; Lingwood, C; Wang, B1
Fisniku, O; Garg, JP; Han, D; Howieson, C; Keirns, J; Wojtkowski, T; Zhu, T1

Trials

1 trial(s) available for adamantane and verapamil

ArticleYear
The Effect of Verapamil, a P-Glycoprotein Inhibitor, on the Pharmacokinetics of Peficitinib, an Orally Administered, Once-Daily JAK Inhibitor.
    Clinical pharmacology in drug development, 2017, Volume: 6, Issue:6

    Topics: Adamantane; Administration, Oral; Adult; Anti-Arrhythmia Agents; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cross-Over Studies; Drug Interactions; Female; Humans; Janus Kinase Inhibitors; Male; Middle Aged; Niacinamide; Verapamil; Young Adult

2017

Other Studies

5 other study(ies) available for adamantane and verapamil

ArticleYear
Analysis of regional hemodynamic regulation in response to scald injury.
    The Journal of clinical investigation, 1994, Volume: 93, Issue:1

    Topics: Adamantane; Animals; Arginine; Atropine; Blood Pressure; Burns; Diphenhydramine; Dogs; Femoral Artery; Hemodynamics; Hindlimb; Histamine; Isoproterenol; Meclofenamic Acid; Methoxamine; Methysergide; Morpholines; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitroglycerin; Pulmonary Circulation; Ranitidine; Regional Blood Flow; Ritanserin; Serotonin; Serotonin Receptor Agonists; Time Factors; Triazines; Ultrasonography; Vascular Resistance; Vasodilation; Verapamil; Xanthines

1994
Pulmonary vasodilation by ketamine is mediated in part by L-type calcium channels.
    Anesthesia and analgesia, 1998, Volume: 87, Issue:4

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adamantane; Anesthetics, Dissociative; Animals; Arachidonic Acid; Arginine; Blood Pressure; Calcium Channel Blockers; Calcium Channels; Cromakalim; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Ketamine; Lung; Male; Meclofenamic Acid; Morpholines; Potassium Channels; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Vasodilation; Verapamil

1998
Sodium reabsorption in thick ascending limb of Henle's loop: effect of potassium channel blockade in vivo.
    British journal of pharmacology, 2000, Volume: 130, Issue:6

    Topics: Adamantane; Animals; Barium; Cesium; Charybdotoxin; Dose-Response Relationship, Drug; Glyburide; Loop of Henle; Male; Models, Biological; Morpholines; Potassium; Potassium Channel Blockers; Potassium Channels; Quinine; Rats; Rats, Wistar; Sodium; Verapamil

2000
Inhibition of human multidrug resistance P-glycoprotein 1 by analogues of a potent delta-opioid antagonist.
    Brain research, 2001, May-25, Volume: 902, Issue:1

    Topics: 3T3 Cells; Adamantane; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Dipeptides; Drug Resistance, Multiple; Fibroblasts; Fluoresceins; Humans; Mice; Narcotic Antagonists; Oligopeptides; Peptides, Cyclic; Receptors, Opioid, delta; Structure-Activity Relationship; Tetrahydroisoquinolines; Transfection; Verapamil

2001
Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog.
    The Journal of biological chemistry, 2008, Feb-22, Volume: 283, Issue:8

    Topics: Adamantane; Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Caco-2 Cells; Calcium Channel Blockers; Cell Membrane; Cell Polarity; Cyclosporine; Dogs; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Endocytosis; Enzyme Inhibitors; Fluorescent Dyes; Golgi Apparatus; Humans; Intestinal Mucosa; Neoplasms; Protein Binding; Protein Structure, Secondary; Protein Synthesis Inhibitors; Protein Transport; Rhodamine 123; Shiga Toxins; Time Factors; Trihexosylceramides; Up-Regulation; Verapamil; Vinblastine

2008